The CEO of Spero Therapeutics sold $207k of stock




The CEO of Spero Therapeutics sold $207k of stock



Source link

  • Related Posts

    Amentum misses initial and lower estimates; reaffirms the outlook for fiscal year 26

    Amentum misses initial and lower estimates; reaffirms the outlook for fiscal year 26 Source link

    Form 144 Roivant Sciences Ltd. For: 9 February

    Form 144 Roivant Sciences Ltd. For: 9 February Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *